Food giant Kerry Group has recently announced the acquisition of Pevesa Biotech, a Spanish specialist in non-allergenic and organic plant proteins. The acquisition is designed to strengthen Kerry’s leading position in hydrolysed plant proteins for specialty nutrition
Pevesa Biotech is an established supplier of non-allergenic, non-GM plant proteins for infant, general and clinical nutrition. Pevesa’s offering includes high-quality plant proteins such as organic rice and pea proteins and protein hydrolysates. Pevesa has also developed a range of organic and standard organic fertilizers for fruit, olive and specialized nurseries and has for many years been strongly focused on developing sustainable solutions to key nutrition, health, biowaste and agricultural challenges.
“Kerry is delighted to bring the global expertise of Pevesa to our leading plant protein portfolio,” said John Reilly, VP Business Development Proteins at Kerry. “Kerry was selected by Pevesa for its expertise, innovation, leadership in producing quality products and patented technology in the non-allergenic plant protein market. It is the perfect complement to Kerry’s growing plant protein product portfolio and customers will benefit from the synergy between Pevesa’s market leading technology and Kerry’s protein processing expertise.”